Carter A J, Laird J R, Farb A, Kufs W, Wortham D C, Virmani R
Cardiology Service, Walter Reed Army Medical Center, Washington, DC.
J Am Coll Cardiol. 1994 Nov 1;24(5):1398-405. doi: 10.1016/0735-1097(94)90126-0.
This study was performed to define the evolution of lesion morphology and its relation to thrombus formation and smooth muscle cell proliferation after experimental coronary stent placement.
Restenosis after percutaneous revascularization may develop because of thrombus accumulation and smooth muscle cell proliferation. In animal models of restenosis, thrombus may assume a significant role in neointimal formation by providing an absorbable matrix into which smooth muscle cells proliferate.
Twenty-eight oversized stents were placed in the coronary arteries of 23 juvenile domestic pigs. The histologic degree of vessel injury, lesion morphometry and smooth muscle cell proliferation measured by immunolocalization with a monoclonal antibody to proliferating cell nuclear antigen (PCNA) were assessed at 24 h and 7, 14 and 28 days after stent placement.
The area of thrombus was minimal at 24 h ([mean +/- SE] 0.44 +/- 0.12 mm2). Neointimal area at 7 days (0.72 +/- 0.20 mm2) was similar to the area of thrombus, followed by a significant increase at 14 days (3.15 +/- 0.39 mm2) and 28 days (3.30 +/- 0.28 mm2) (p < 0.0036, 24 h and 7 days vs. 14 and 28 days). At 14 and 28 days, neointimal thickness correlated with the histologic degree of vessel injury (p < 0.003). In arteries with severe injury, the increase in neointimal thickness is accounted for by replacement of the damaged media. The smooth muscle cell proliferation index was 18.6 +/- 3.5% at 7 days compared with 9.6 +/- 1.3% by 14 days (p = 0.0247) and declined to 1.1 +/- 0.97% by 28 days (p < 0.008, 7 and 14 days vs. 28 days).
Early thrombus formation is minimal, and thrombus accounts for a small portion of subsequent neointimal formation. Smooth muscle cell proliferation and matrix formation are the major factors relating to neointimal formation in this proliferative model of restenosis. The evolution of neointimal formation after coronary stenting shows maximal smooth muscle cell proliferation at 7 days, with a decline to low levels by 28 days. Therefore, these data may be useful for developing effective therapies for restenosis.
本研究旨在明确实验性冠状动脉支架置入术后病变形态的演变及其与血栓形成和平滑肌细胞增殖的关系。
经皮血管重建术后再狭窄可能因血栓积聚和平滑肌细胞增殖而发生。在再狭窄的动物模型中,血栓可能通过提供可吸收基质,使平滑肌细胞在其中增殖,从而在新生内膜形成中发挥重要作用。
将28个超大尺寸支架置入23只幼年家猪的冠状动脉。在支架置入后24小时以及7、14和28天,评估血管损伤的组织学程度、病变形态测量以及通过增殖细胞核抗原(PCNA)单克隆抗体免疫定位测量的平滑肌细胞增殖情况。
血栓面积在24小时时最小([均值±标准误]0.44±0.12平方毫米)。7天时的新生内膜面积(0.72±0.20平方毫米)与血栓面积相似,随后在14天(3.15±0.39平方毫米)和28天(3.30±0.28平方毫米)显著增加(24小时和7天与14天和28天相比,p<0.0036)。在14天和28天时,新生内膜厚度与血管损伤的组织学程度相关(p<0.003)。在严重损伤的动脉中,新生内膜厚度的增加是由于受损中膜的替代。平滑肌细胞增殖指数在7天时为18.6±3.5%,14天时为9.6±1.3%(p=0.0247),到28天时降至1.1±0.97%(7天和14天与28天相比,p<0.008)。
早期血栓形成极少,且血栓在随后的新生内膜形成中占比小。平滑肌细胞增殖和基质形成是该再狭窄增殖模型中与新生内膜形成相关的主要因素。冠状动脉支架置入术后新生内膜形成的演变显示,平滑肌细胞增殖在7天时达到最大值,到28天时降至低水平。因此,这些数据可能有助于开发有效的再狭窄治疗方法。